C

CytoMed Therapeutics Ltd
NASDAQ:GDTC

Watchlist Manager
CytoMed Therapeutics Ltd
NASDAQ:GDTC
Watchlist
Price: 1.53 USD -0.65% Market Closed
Market Cap: 17.9m USD

Wall Street
Price Targets

GDTC Price Targets Summary
CytoMed Therapeutics Ltd

There are no price targets for GDTC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
CytoMed Therapeutics Ltd Competitors:
Price Targets
6160
Beigene Ltd
36% Upside
NIOX
Niox Group PLC
23% Upside
MRNA
Moderna Inc
20% Upside
ENTA
Enanta Pharmaceuticals Inc
16% Upside
PRME
Prime Medicine Inc
88% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
49% Upside
DVYSR
Devyser Diagnostics AB
49% Upside
SBTX
SkinBioTherapeutics PLC
108% Upside

Revenue
Forecast

Revenue Estimate
CytoMed Therapeutics Ltd

The compound annual growth rate of CytoMed Therapeutics Ltd's revenue for the next 1 year is 663%.

N/A
Past Growth
663%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CytoMed Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CytoMed Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GDTC's stock price target?
Not Available

GDTC doesn't have any price targets made by Wall Street professionals.

What is CytoMed Therapeutics Ltd's Revenue forecast?
Projected CAGR
663%

The compound annual growth rate of CytoMed Therapeutics Ltd's revenue for the next 1 year is 663%.

Back to Top